Lee H, Lee B, Shekhtman T, Park Y, Kelsoe J
Clin Psychopharmacol Neurosci. 2024; 22(4):585-593.
PMID: 39420606
PMC: 11494434.
DOI: 10.9758/cpn.23.1152.
Lenk H, Koch E, OConnell K, Smith R, Akkouh I, Djurovic S
Hum Genomics. 2024; 18(1):108.
PMID: 39334510
PMC: 11438281.
DOI: 10.1186/s40246-024-00673-x.
Detanac M, Williams C, Dragovic M, Shymko G, John A
Aust N Z J Psychiatry. 2024; 58(12):1080-1089.
PMID: 39198966
PMC: 11585183.
DOI: 10.1177/00048674241274314.
Singh S, Stocco G, Theken K, Dickson A, Feng Q, Karnes J
Clin Transl Sci. 2024; 17(8):e13893.
PMID: 39078255
PMC: 11287822.
DOI: 10.1111/cts.13893.
Qubad M, Dupont G, Hahn M, Martin S, Puntmann V, Nagel E
CNS Drugs. 2024; 38(9):671-696.
PMID: 38951464
PMC: 11316720.
DOI: 10.1007/s40263-024-01100-4.
Association of variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia.
Kogure M, Kanahara N, Miyazawa A, Shiko Y, Otsuka I, Matsuyama K
Front Psychiatry. 2024; 14:1334335.
PMID: 38476817
PMC: 10929739.
DOI: 10.3389/fpsyt.2023.1334335.
Complex neuropsychiatric presentation of 17q12 duplication syndrome: A case report.
Das S, Samarasinghe L, Deva S, Co E, Poudel S, Dave T
SAGE Open Med Case Rep. 2024; 12:2050313X241233184.
PMID: 38379631
PMC: 10878203.
DOI: 10.1177/2050313X241233184.
Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study.
Koch E, Kampe A, Alver M, Sigurdarson S, Einarsson G, Partanen J
Neuropsychopharmacology. 2024; 49(7):1113-1119.
PMID: 38184734
PMC: 11109158.
DOI: 10.1038/s41386-023-01792-0.
Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities.
Zhai S, Mehrotra D, Shen J
Brief Bioinform. 2023; 25(1).
PMID: 38152980
PMC: 10782924.
DOI: 10.1093/bib/bbad470.
Genomic findings in schizophrenia and their implications.
Owen M, Legge S, Rees E, Walters J, ODonovan M
Mol Psychiatry. 2023; 28(9):3638-3647.
PMID: 37853064
PMC: 10730422.
DOI: 10.1038/s41380-023-02293-8.
Schizophrenia polygenic risk score and type 2 diabetes onset in older adults with no schizophrenia diagnosis.
Shamsutdinova D, Ajnakina O, Roberts A, Stahl D
Psychiatr Genet. 2023; 33(5):191-201.
PMID: 37477360
PMC: 10501355.
DOI: 10.1097/YPG.0000000000000349.
Polygenetic risk scores and phenotypic constellations of obsessive-compulsive disorder in clozapine-treated schizophrenia.
Morgenroth C, Kleymann P, Ripke S, Awasthi S, Wagner E, Oviedo-Salcedo T
Eur Arch Psychiatry Clin Neurosci. 2023; 274(1):181-193.
PMID: 37020043
PMC: 10786740.
DOI: 10.1007/s00406-023-01593-y.
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia.
Qubad M, Bittner R
Ther Adv Psychopharmacol. 2023; 13:20451253231158152.
PMID: 36994117
PMC: 10041648.
DOI: 10.1177/20451253231158152.
Genomic Stratification of Clozapine Prescription Patterns Using Schizophrenia Polygenic Scores.
Kappel D, Legge S, Hubbard L, Willcocks I, OConnell K, Smith R
Biol Psychiatry. 2022; 93(2):149-156.
PMID: 36244804
PMC: 10804961.
DOI: 10.1016/j.biopsych.2022.07.014.
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Pardinas A, Smart S, Willcocks I, Holmans P, Dennison C, Lynham A
JAMA Psychiatry. 2022; 79(3):260-269.
PMID: 35019943
PMC: 8756361.
DOI: 10.1001/jamapsychiatry.2021.3799.
Obstetric Complications and Polygenic Risk Score: Which Role in Predicting a Severe Short-Term Outcome in Psychosis?.
Tosato S, Bonetto C, Vassos E, Lasalvia A, De Santi K, Gelmetti M
Genes (Basel). 2021; 12(12).
PMID: 34946845
PMC: 8702213.
DOI: 10.3390/genes12121895.
Polygenic risk scores across the extended psychosis spectrum.
Smigielski L, Papiol S, Theodoridou A, Heekeren K, Gerstenberg M, Wotruba D
Transl Psychiatry. 2021; 11(1):600.
PMID: 34836939
PMC: 8626446.
DOI: 10.1038/s41398-021-01720-0.
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.
Erzin G, Pries L, van Os J, Fusar-Poli L, Delespaul P, Kenis G
Eur Psychiatry. 2021; 64(1):e25.
PMID: 33736735
PMC: 8080213.
DOI: 10.1192/j.eurpsy.2021.19.
Do we measure or compute polygenic risk scores? Why language matters.
Penders B, Janssens A
Hum Genet. 2021; 141(5):1093-1097.
PMID: 33587168
DOI: 10.1007/s00439-021-02262-7.
Polygenic risk for autism spectrum disorder affects left amygdala activity and negative emotion in schizophrenia.
Qin Y, Kang J, Jiao Z, Wang Y, Wang J, Wang H
Transl Psychiatry. 2020; 10(1):322.
PMID: 32958750
PMC: 7506524.
DOI: 10.1038/s41398-020-01001-2.
